• ქართული
  • English
  • AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal

    AstraZeneca Plc will pay up to $6.9 billion to work with Daiichi Sankyo Co Ltd on a hotly-tipped experimental treatment for breast cancer, in a direct challenge to the world’s biggest cancer drug maker Roche.

    Market Quotes by TradingView